InsiderTrades.com logo
The Gold Grab of the Century
From Colonial Metals   |   Ad
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
That's why we have released our Free Precious Metals Investment Guide.
Keith Orford net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Keith Orford Biography and Net Worth

Director of Calithera Biosciences
Dr. Orford is Chief Medical Officer. Since joining Calithera in 2015, he has overseen clinical development activities, including Clinical Operations and Medical Affairs. Prior to joining Calithera, Dr. Orford was the Clinical Development Lead in the Immuno-Oncology and Combinations Development Performance Unit at GlaxoSmithKline, where he oversaw the clinical activities on multiple early stage clinical trials with targeted agents and novel immune-based therapies. Prior to GlaxoSmithKline, Dr. Orford was at Merck, where he worked on early clinical development programs across oncology and other therapeutic areas. Previously, Dr. Orford was a Research Fellow and Instructor at Massachusetts General Hospital and Harvard Medical School, where he completed clinical training in Internal Medicine, as well as postdoctoral work studying the epigenetic regulation of hematopoietic and embryonic stem cell differentiation. Dr. Orford received his undergraduate, M.D., and Ph.D. degrees from Georgetown University.

What is Keith Orford's net worth?

The estimated net worth of Keith Orford is at least $200.00 as of May 22nd, 2019. Dr. Orford owns 10,000 shares of Calithera Biosciences stock worth more than $200 as of April 26th. This net worth approximation does not reflect any other investments that Dr. Orford may own. Learn More about Keith Orford's net worth.

How do I contact Keith Orford?

The corporate mailing address for Dr. Orford and other Calithera Biosciences executives is 343 OYSTER POINT BLVD. SUITE 200, SOUTH SAN FRANCISCO CA, 94080. Calithera Biosciences can also be reached via phone at (650) 870-1000 and via email at [email protected]. Learn More on Keith Orford's contact information.

Has Keith Orford been buying or selling shares of Calithera Biosciences?

Keith Orford has not been actively trading shares of Calithera Biosciences in the last ninety days. Most recently, Keith Orford sold 48,190 shares of the business's stock in a transaction on Thursday, November 11th. The shares were sold at an average price of $0.88, for a transaction totalling $42,407.20. Learn More on Keith Orford's trading history.

Who are Calithera Biosciences' active insiders?

Calithera Biosciences' insider roster includes Susan Molineaux (CEO), and Keith Orford (Director). Learn More on Calithera Biosciences' active insiders.

Keith Orford Insider Trading History at Calithera Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2021Sell48,190$0.88$42,407.20View SEC Filing Icon  
11/9/2021Sell51,810$0.84$43,520.40View SEC Filing Icon  
12/16/2020Sell2,447$6.00$14,682.00View SEC Filing Icon  
6/17/2019Sell417$6.00$2,502.00View SEC Filing Icon  
5/22/2019Sell416$6.00$2,496.0010,000View SEC Filing Icon  
4/15/2019Sell416$6.33$2,633.2810,416View SEC Filing Icon  
3/15/2019Sell417$6.43$2,681.3110,832View SEC Filing Icon  
3/11/2019Sell1,565$6.00$9,390.00View SEC Filing Icon  
10/15/2018Sell313$6.05$1,893.6510,314View SEC Filing Icon  
10/11/2018Sell1,252$6.00$7,512.00View SEC Filing Icon  
7/17/2017Sell2,120$18.31$38,817.20View SEC Filing Icon  
See Full Table

Keith Orford Buying and Selling Activity at Calithera Biosciences

This chart shows Keith Orford's buying and selling at Calithera Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Calithera Biosciences Company Overview

Calithera Biosciences logo
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $0.02
Low: $0.02
High: $0.02

50 Day Range

MA: $0.02
Low: $0.02
High: $0.05

2 Week Range

Now: $0.02
Low: $0.01
High: $0.50

Volume

191 shs

Average Volume

822 shs

Market Capitalization

$97,400.00

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
The Gold Grab of the Century
From Colonial Metals   |   Ad
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
That's why we have released our Free Precious Metals Investment Guide.